CASP3 and amyotrophic lateral sclerosis: There was a 1.9- and 2.2-fold increase in the level of cleaved caspase 3 when treated with ALS at 1 and 5 μM for 48 h, respectively, compared to the control cells (p < 0.01; Figure 5B and Figure S5B).